Female Heart Workshop 2024
An exceptionally inspiring workshop of high scientific quality, bringing together participants from all medical faculties in Norway, along with invited speakers from Spain, Italy, and Iceland.
Published: (Updated: )
This year’s Female Heart Workshop opened with a powerful session on sex differences in hypertension. Professor Claudio Borghi from the University of Bologna delivered a lecture on sex-specific differences in antihypertensive treatment, with a focus on drug efficacy, adverse effects, and underlying regulatory mechanisms. Senior consultant Lene Halvorsen from Oslo University Hospital Ullevål presented the main findings from the national IDA study, which investigates medication adherence among patients with uncontrolled hypertension despite pharmacological therapy. Postdoctoral Fellow Trond Pettersen from the ProCard research group at the Department of Heart Disease, Haukeland University Hospital, shared results from his study on sex differences in the use and side effects of cardiovascular medications among patients with coronary artery disease.
PhD candidates from UiT, NTNU, and UiB presented their own data and gained valuable experience discussing their findings with both junior and senior researchers.
The workshop also featured a session dedicated to the use of multiomics to improve our understanding of mechanisms underlying sex differences in cardiovascular disease. This session was organized in collaboration with the EU-funded COST Action AtheroNet. Professor George Kararigas presented sex differences in translational studies of cardiac remodeling, Professor Kirsten Holven shared new insights into how elevated cholesterol contributes to heart disease in women, and Postdoctoral Fellow Hilde Halland presented her data on how proteomics reveals distinct pathophysiological mechanisms of obesity-associated inflammation.
If you missed these sessions—and much more—there will be new opportunities at the next Female Heart Workshop on 8–9 May 2025.
